Penserra Capital Management’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Penserra Capital Management’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-670	Closed	-$40K	–	1441
2021 Q1	$40K	Sell	670 -30	-4%	-$1.09K	﹤0.01%	853
2020 Q4	$10K	Buy	+700	New	+$9.74K	﹤0.01%	929

Penserra Capital Management's PAND Position: Q2 2021 in Review

Penserra Capital Management sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 670 shares — an estimated $40K sold.

Penserra Capital Management first reported a position in PAND in Q4 2020 and held it in 2 quarters. The position peaked at $40K in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

Penserra Capital Management reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Penserra Capital Management sold 670 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $40K.
Penserra Capital Management first reported a position in Pandion Therapeutics Inc. Common Stock in Q4 2020 and held it in 2 quarters.
Penserra Capital Management's Pandion Therapeutics Inc. Common Stock position peaked at $40K in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Penserra Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.